[The immunomodulating and metabolic actions of thymalin in an experimental herpetic infection].
Chukhlovina. M L ML; Tsinzerling. V A VA; Zalkind. L G LG; Polushkina. L I LI; Nilova. L G LG; Mazing. Iu A IuA; Kuz'min. V O VO
Key Findings
- Herpes infection lowered macrophage phagocytosis and leukocyte response to PHA.
- Thymalin treatment restored phagocytic activity and leukocyte responsiveness.
- Thymalin normalized liver enzymes involved in gluconeogenesis, reduced lipid peroxidation, and kept blood glucose and HbA1c levels closer to normal.
Practical Outcomes
- Thymalin shows promise as an immune and metabolic support agent in a mouse infection model, but there are no human studies or dosing guidelines yet. Biohackers should view this as early‑stage evidence and wait for clinical data before adding it to personal protocols.
Summary
In mice infected with herpes virus, the drug thymalin helped the immune cells work better and kept liver metabolism more normal, suggesting it has both immune‑boosting and metabolic benefits in this animal model.
Abstract
In experiments on the intracerebral inoculation of herpes virus, type I, into 38 CBA mice the phagocytic activity of peritoneal exudate, cells, spontaneous migration of leukocytes and their response to phytohemagglutinin (PHA), the activity of key enzymes of gluconeogenesis, lipid peroxidation in liver tissue, as well as the level of glucose and glycosylated hemoglobin in the blood, were determined simultaneously with the histological study of the brain and the main internal organs of the animals, receiving thymalin treatment and not receiving it. As demonstrated in these experiments, the development of experimental infection was accompanied by the inhibition of the phagocytic activity of peritoneal macrophages and response of leukocytes to PHA, as well as metabolic shifts in liver tissue. Treatment with thymalin produced a combined immunomodulating and metabolic effect.
Study Information
pubmed
1994